Protalix Biotherapeutics Inc (NYSE American:PLX)

3.51
Delayed Data
As of 4:00pm ET
 -0.04 / -1.13%
Today’s Change
1.85
Today|||52-Week Range
4.87
+7.01%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +213.39% increase from the last price of 3.51.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Protalix Biotherapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.08
Sales
$13.6M
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 38.46%
 
 
 
 
 
 
Growthannually 84.55%
 
 
 
 
 
 

Sales

Growthquarterly 23.63%
 
 
 
 
 
 
Growthannually 12.03%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.